Celebrating a decade of In Touch!
This year our In Touch group turned 10 years old. Together, we've built a kind, supportive group for those living with ovarian cancer, across the UK.
News
Read our latest updates from research breakthroughs to government actions to fundraising heroes.
Draft NICE guidance does not recommend use of Elahere by NHS in England
NICE has produced draft guidance that has recommended that Mirvetuximab soravtansine (Elahere) is not used by the NHS in England
Putting ovarian cancer on the agenda at Labour Party Conference
This week, we joined charity sector colleagues and policy makers at the Labour Party Conference in Liverpool, using the opportunity to raise awareness of the challenges facing women diagnosed with ovarian cancer and to advocate for urgent policy change.
Team Target raise over £40k at the Great North Run 2025
Laura, Andy, Lewis and Josie share their motivations for taking on this legendary half marathon and why they wanted to use the opportunity to support Target Ovarian Cancer.
New ways to learn and connect: genetics animations, digital events & support groups
We’ve launched new resources to support people with ovarian cancer, including animations on genetic testing, peer support groups across England, and upcoming digital events.
September is Gynaecological Cancer Awareness Month
Gynae Cancer Awareness Month is from 1-30 September and is a chance to shine a spotlight on ovarian cancer as one of the five gynaecological cancers.
‘This Van Can…’ and it did!
This spring, as part of our activity for Ovarian Cancer Awareness Month, we partnered with the NHS Greater Manchester Cancer Alliance and the Dianne Oxberry Trust to go on tour around Greater Manchester
Our campaign for cervical screening leaflets update
Last month, we were delighted to learn that the leaflet inviting women in England to attend their smear tests will now contain additional wording to state that cervical screening does not detect ovarian cancer.
It’s time to talk this Ethnic Minority Cancer Awareness Month
After being diagnosed with Stage 3 ovarian cancer in 2023, Reeta reflects on those early days after diagnosis and the importance of being able to talk about it – especially within communities where open discussions may be more challenging.
In memory of Sir Kenneth Calman
Remembering our founding patron, Sir Kenneth Calman, who passed away on 21 July 2025
New research project exploring effective and safe immunotherapy against low grade serous ovarian cancer
Led by Dr Jun Ishihara at Imperial College London, this three-year project will test a new and original immunotherapy (CBD-IL-12) for low grade serous ovarian cancer.
Driving change through knowledge - updated NHS cervical screening guide
The NHS cervical screening guide in England has been updated - a change that we've been campaigning for for over a decade!
